Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCapital Metals Regulatory News (CMET)

Share Price Information for Capital Metals (CMET)

Share Price is delayed by 15 minutes
Get Live Data
5.15    -0.10 (-1.90%)
Bid:
5.00
Ask:
5.30
Spread: 0.30 (6.00%)
Market Cap: £25.35m
CMET Live PriceLast checked at - London Stock Exchange

Intraday Capital Metals Share Chart

Director/PDMR Shareholding - Replacement

8 Jul 2024 07:00

RNS Number : 4058V
Capital Metals PLC
08 July 2024
Β 

8 July 2024

Β 

The following amendment has been made to the 'Director/PDMR Shareholding' announcement released on 5 July 2024 at 3.23pm under RNS Number 3758V.

Β 

The announcement incorrectly stated that following the purchase of shares James Leahy's shareholding was 2,350,000 shares representing 0.68% of the Company's issued share capital. The correct number is 538,333 shares representing 0.16% of the Company's issued share capital.

Β 

All other details remain unchanged.

Β 

The full amended text is shown below.

Β 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

Β 

Capital Metals plc

Β 

("Capital Metals" or the "Company")

Β 

Director / PDMR Shareholding - Replacement

Β 

Capital Metals (AIM: CMET), a mineral sands company approaching mine development stage at the high-grade Eastern Minerals Project in Sri Lanka (the "Project"), announces that James Leahy, Non-Executive Director, purchased 350,000 ordinary shares of 0.2 pence each ("Ordinary Shares") in the Company on 5 July 2024.

Β 

Following this purchase, Mr Leahy holds 538,333 Ordinary Shares representing 0.16% of the Company's issued share capital.

Β 

For further information, please visit www.capitalmetals.com or contact:

Β 

Capital Metals plc

Greg Martyr (Executive Chairman)

Via Vigo Consulting

Vigo Consulting (Investor Relations)

Ben Simons / Peter Jacob

+44 (0)20 7390 0234

capitalmetals@vigoconsulting.com

SPARK Advisory Partners (Nominated Adviser)

Neil Baldwin / James Keeshan

+44 (0)20 3368 3554

Tavira Financial

Jonathan Evans / Oliver Stansfield

+44 (0)20 7100 5100

Β 

About Capital Metals

Β 

Capital Metals is a UK company listed on the London Stock Exchange (AIM: CMET). We are developing the Eastern Minerals Project in Sri Lanka, approximately 220km east of Colombo, containing industrial minerals including ilmenite, rutile, zircon, and garnet. The Project is one of the highest-grade mineral sands projects globally, with potential for further grade and resource expansion. In 2022, a third-party Preliminary Economic Assessment provided a Project NPV of US$155-235m based on existing resources, with further identified optimisation potential. We are committed to applying modern mining practices and bringing significant positive benefits to Sri Lanka and the local community. We expect over 300 direct new jobs to be created and over US$130m in direct government royalties and taxes to be paid.

Β 

Appendix - Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

Β 

Β 

Β 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

James Leahy

2.

Reason for notification

a)

Position/Status

Non-Executive Director

b)

Initial notification/

Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Capital Metals plc

b)

LEI

213800RR4MW1ETEMS859

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrumentIdentification Code

Ordinary shares of 0.2 pence per share par value

Β 

ISIN: GB00BMF75608

b)

Nature of the transaction

Acquisition of ordinary shares

c)

Price(s) and volume(s)

Β 

Β 

Β 

Price(s)

Volume(s)

1.78p

350,000

d)

Aggregated information

Β 

- Aggregated Volume

Β 

- Price

Single transaction as in 4 c) above

Β 

Price(s)

Volume(s)

1.78p

350,000

e)

Date of the transaction

5 July 2024

f)

Place of the transaction

On market

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHUPUWPMUPCPGM
Date   Source Headline
12th Mar 20269:14 amRNSIssue of Equity & Total Voting Rights
12th Mar 20269:14 amRNSIssue of Equity & Total Voting Rights
2nd Mar 20267:00 amRNSProject Updates & Notice of Investor Webinar
11th Feb 20269:06 amRNSPublication of New National Minerals Policy
6th Feb 20267:00 amRNSHolding in Company & Directorate Change
28th Jan 20267:00 amRNSHolding in Company
19th Jan 202611:29 amRNSIssue of Equity & Total Voting Rights
18th Dec 20257:00 amRNSHalf-year Report
10th Dec 202511:30 amRNSCyclone Ditwah - Update on Sri Lanka Operations
17th Nov 20252:17 pmRNS-RNotice of Investor Webcast
17th Nov 20257:00 amRNSMineral Resource Upgrade
6th Nov 20257:00 amRNS-RIndustry Conference Presentation
14th Oct 20252:26 pmRNSIssue of Equity and Warrants; Total Voting Rights
1st Oct 20259:15 amRNSHolding(s) in Company
23rd Sep 20251:56 pmRNSResult of Annual General Meeting
22nd Sep 20257:00 amRNS-RNotice of Investor Webcast & Updated Presentation
18th Sep 20257:36 amRNSProject Updates
15th Sep 20257:00 amRNS3rd Batch of Drill Assay Results
12th Sep 202512:07 pmRNSHolding(s) in Company
12th Sep 202512:01 pmRNSHolding(s) in Company
12th Sep 202511:53 amRNSHolding(s) in Company
12th Sep 202510:53 amRNSHolding(s) in Company
12th Sep 202510:49 amRNSHolding(s) in Company
11th Sep 202512:31 pmRNSHolding(s) in Company
9th Sep 202512:29 pmRNSHolding(s) in Company
5th Sep 20251:31 pmRNSHolding(s) in Company
4th Sep 20257:16 amRNSSheffield Subscription/Grant of Options
2nd Sep 20252:52 pmRNSHolding(s) in Company
2nd Sep 202511:00 amRNSFull Exercise of Ambeon Option and TVR
29th Aug 20254:00 pmRNSNotice of Annual General Meeting
20th Aug 20257:00 amRNSChange of Reg. Office; CFO & CoSec Appointment
19th Aug 20257:57 amRNSFurther Extension of Ambeon Option Period
18th Aug 20257:00 amRNSFinal Results
12th Aug 20254:31 pmRNSExtension of Ambeon Option Period
5th Aug 20257:00 amRNSFirst Tranche of Ambeon Option Exercised
4th Aug 20257:53 amRNSAppointment of Non-Executive Directors
29th Jul 20257:00 amRNSAppointment of Nominated Adviser
28th Jul 20257:14 amRNS2nd Batch of Drill Assay Results
16th Jul 20259:00 amRNSAmbeon Option Extension, Share Options Grant & TVR
16th Jul 20258:46 amRNSInitial Drill Assay Results
13th Jun 20257:00 amRNSRem. Plan, Issue of Equity, Director Shareholding
11th Jun 20257:00 amRNSDrilling Update
2nd Jun 20257:00 amRNSResult of WRAP Retail Offer, Issue of Equity & TVR
30th May 20251:41 pmRNSClose of WRAP Retail Offer
29th May 202511:11 amRNS-RInitiation of Research by Hannam & Partners
29th May 20257:16 amRNSWRAP Retail Offer for up to £300,000
29th May 20257:00 amRNSStrategic Investment & Project Development MoU
2nd Apr 20251:07 pmRNSIssue of Equity
26th Mar 20257:00 amRNSDrilling Update
5th Mar 20257:00 amRNSAppointment of Broker & Financial Advisor

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.